Middle East Pharmaceutical Market Expected to Grow by 15% Annually, says New Report

The pharmaceutical market in the Middle East is likely to grow by between ten and 15 percent annually over the next three years, outstripping more mature markets, forecasts a report from URCH Publishing. End Quote

(1888PressRelease) February 17, 2009 - Major Pharmaceutical Markets of the Middle East (2nd Ed): An overview of Egypt, Israel, Jordan, Lebanon, Saudi Arabia & UAE, says that massive growth is being forecast for the pharmaceutical and biotechnology markets of Middle Eastern states, driven by moves to liberalise national economies, the introduction of mass health insurance and the determination of the region’s governments to become self-sufficient in pharmaceuticals production.

All these factors are leading to huge investments taking place in both the private and public health sectors, with major benefits to the pharmaceutical industry.

The population of the Middle East now exceeds 370 million and is expected to reach over 520 million by 2030. The growing population, dominated mainly by the expatriate community in most of the Gulf Corporation Council (GCC) countries, has given rise to a rapidly growing market for healthcare and its associated industries, which is estimated at $75bn in the Middle East alone.

The biggest threat to pharmaceutical market growth is the heavy reliance on the fluctuating price of oil, which dictates the strength of their economies and, in turn, is reflected in healthcare provision and the pharmaceutical market.

This report is the second edition of the 2006 best-selling version. Fully updated, the 90 page report provides necessary information for pharmaceutical companies to operate in the Middle East region. Country coverage includes:
- Egypt, the largest pharmaceutical market of the region
- Israel, home to the world’s largest generic drug company
- Jordan, the leading Arab pharmaceutical exporter
- Lebanon, an almost exclusive import market
- Saudi Arabia, the largest market of the Gulf
- The United Arab Emirates, among the highest-priced markets in the region

Major Pharmaceutical Markets of the Middle East (2nd Ed) is available from URCH Publishing. Find more details about this 90 page report priced at £1,295 at
www.urchpublishing.com/publications/general/middle_east_pharma.html

About URCH Publishing Ltd
URCH Publishing Ltd is an independent business information publisher dedicated to delivering quality information products to the global pharmaceuticals industry. For more information contact Urch Publishing on +44 (0) 20 7060 1099 or email press[a]urchpublishing.com.

###

Visit Urch Publishing Website

space